Financial Summary (All financials)
| In millions of CNY, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 8,521.0 | 3,819.7 | 1,549.4 | 132.6 |
| Revenue growth | 123.1% | 146.5% | 1068.3% | |
| Cost of goods sold | 4,848.9 | 2,292.2 | 968.4 | 73.4 |
| Gross profit | 3,672.1 | 1,527.6 | 580.9 | 59.2 |
| Gross margin | 43.1% | 40.0% | 37.5% | 44.7% |
| Sales and marketing | 520.7 | 443.2 | 359.4 | 34.3 |
| Research and development | 179.9 | 299.3 | 31.9 | 2.1 |
| General and administrative | 672.7 | 772.0 | 133.2 | 20.7 |
| EBITA | 2,303.5 | 16.5 | 57.2 | 2.2 |
| EBITA margin | 27.0% | 0.4% | 3.7% | 1.7% |
| Amortization of intangibles | 4.8 | 3.4 | 0.8 | |
| EBIT | 2,298.7 | 13.1 | 56.4 | 2.2 |
| EBIT margin | 27.0% | 0.3% | 3.6% | 1.7% |
| Pre-tax income | 2,659.6 | 102.4 | 73.7 | 2.1 |
| Income taxes | 631.4 | 230.5 | 25.9 | 2.4 |
| Tax rate | 23.7% | 225.1% | 35.2% | 113.7% |
| Net income | 2,024.7 | -128.1 | 47.7 | -0.3 |
| Net margin | 23.8% | -3.4% | 3.1% | -0.2% |
| |
| Diluted EPS | $1.44 | ($0.09) | $0.03 | $0.00 |
| Shares outstanding (diluted) | 1,409.7 | 1,436.8 | 1,436.8 | 1,194.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|